Incorporating daffodil-derived galanthamine production into upland grassland systems

Mariecia Fraser, John Richard Thomas Davies, Gareth Edwin Rowlands, Xianmin Chang

Allbwn ymchwil: Cyfraniad at gynhadleddPapuradolygiad gan gymheiriaid


Galantamine is a pharmaceutical compound that has been an approved Alzheimer's disease treatment since 1998. Galantamine can be produced from the alkaloid galanthamine extracted from plants, but supplies are limited. Daffodils (Narcissus spp.) are the only economically feasible plant source for cultivation in many parts of the world. An initial study tested an innovative approach for producing daffodil-derived galanthamine based on integrating daffodil growing into existing marginal pasture; avoiding the need to plough the land. Experimental lines of daffodils were established under upland permanent pasture. Over 80% of bulbs successfully established at each site. There was no effect of planting site or planting density on galanthamine concentrations within vegetative tissues, which were higher than anticipated. The results confirm that planting daffodils under grass in upland areas could offer a novel and sustainable source of plant-derived galanthamine. The findings have the potential to increase the economic sustainability of farming communities in less favoured areas by providing farmers with a high value crop while maintaining traditional farming systems
Iaith wreiddiolSaesneg
Nifer y tudalennau3
StatwsCyhoeddwyd - 2017
Digwyddiad19th EGF Symposium 2017: Grassland resources for extensive farming systems in marginal lands: major drivers and future scenarios - Sardinia, Yr Eidal
Hyd: 07 Mai 201710 Mai 2017


Cynhadledd19th EGF Symposium 2017
Gwlad/TiriogaethYr Eidal
Cyfnod07 Mai 201710 Mai 2017

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'Incorporating daffodil-derived galanthamine production into upland grassland systems'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Dyfynnu hyn